Iztok Takač

Prof. Dr. Iztok Takač

Divison of Gynecology and Perinatology, University Medical Centre Maribor, 2000 Maribor, Slovenia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TPTjaša Padežnik
Tjaša Padežnik
AOAnja Oleksy
Anja Oleksy
ACAndrej Cokan
Andrej Cokan
Iztok TakačIztok Takač
Iztok Takač
Monika SobocanMonika Sobocan
Monika Sobocan
Endometrial and cervical cancers are the two most common gynaecological malignancies and among the leading causes of death worldwide. The extracellular matrix (ECM) is an important component of the cellular microenvironment and plays an important role in developing and regulating normal tissues and homeostasis. The pathological dynamics of the ECM contribute to several different processes such as endometriosis, infertility, cancer, and metastasis. Identifying changes in components of ECM is crucial for understanding the mechanisms of cancer development and its progression. We performed a systematic analysis of publications on the topic of changes in the extracellular matrix in cervical and endometrial cancer. The findings of this systematic review show that matrix metalloproteinases (MMP) play an important role impacting tumour growth in both types of cancer. MMPs degrade various specific substrates (collagen, elastin, fibronectin, aggrecan, fibulin, laminin, tenascin, vitronectin, versican, nidogen) and play a crucial role in the basal membrane degradation and ECM components. Similar types of MMPs were found to be increased in both cancers, namely, MMP-1, MMP-2, MMP-9, and MMP-11. Elevated concentrations of MMP-2 and MMP-9 were correlated with the FIGO stage and are associated with poor prognosis in endometrial cancer, whereas in cervical cancer, elevated concentrations of MMP-9 have been associated with a better outcome. Elevated ADAMTS levels were found in cervical cancer tissues. Elevated disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) levels were also found in endometrial cancer, but their role is still unclear. Following these findings, this review reports on tissue inhibitors of ECM enzymes, MMPs, and ADAMTS. The present review demonstrates changes in the extracellular matrix in cervical and endometrial cancers and compared their effect on cancer development, progression, and patient prognosis.

1 June 2018 in Clinica Chimica Acta
Verified
Journal Article
Closed access
NKNejc Kozar
Nejc Kozar
KKKristi Kruusmaa
Kristi Kruusmaa
MBMarko Bitenc
Marko Bitenc
RARosa Argamasilla
Rosa Argamasilla
AAAntonio Adsuar
Antonio Adsuar
Iztok TakačIztok Takač
Iztok Takač

1 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MBMaša Brumec
Maša Brumec
Monika SobocanMonika Sobocan
Monika Sobocan
Iztok TakačIztok Takač
Iztok Takač
Darja ArkoDarja Arko
Darja Arko
This review summarizes the recent findings of a vast array of studies conducted on androgen receptor-positive triple-negative breast cancer (AR-positive TNBC) to provide a better understanding of this specific breast cancer subgroup. AR expression is correlated with higher age, lower histological grade, lower proliferation index Ki-67, spiculated masses, and calcifications on mammography. Studies investigating the correlation between AR expression and lymph node metastasis are highly discordant. In addition, results regarding prognosis are highly contradictory. AR antagonists are a promising novel therapeutic approach in AR-positive TNBC. However, AR signaling pathways should be more investigated in order to understand the influence of AR expression on TNBC more thoroughly.

17 December 2019 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
Kristijan SkokKristijan Skok
Kristijan Skok
Uroš MaverUroš Maver
Uroš Maver
LGLidija Gradišnik
Lidija Gradišnik
NKNejc Kozar
Nejc Kozar
Iztok TakačIztok Takač
Iztok Takač
Darja ArkoDarja Arko
Darja Arko

14 January 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Monika SobocanMonika Sobocan
Monika Sobocan
SBSuzana Bračič
Suzana Bračič
Jure KnezJure Knez
Jure Knez
Iztok TakačIztok Takač
Iztok Takač
JHJohannes Haybäck
Johannes Haybäck
Studies of the mechanistic (mammalian) target of rapamycin inhibitors (mTOR) represent a step towards the targeted treatment of gynecological cancers. It has been shown that women with increased levels of mTOR signaling pathway targets have worse prognosis compared to women with normal mTOR levels. Yet, targeting mTOR alone has led to unsatisfactory outcomes in gynecological cancer. The aim of our review was therefore to provide an overview of the most recent clinical results and basic findings on the interplay of mTOR signaling and cold shock proteins in gynecological malignancies. Due to their oncogenic activity, there are promising data showing that mTOR and Y-box-protein 1 (YB-1) dual targeting improves the inhibition of carcinogenic activity. Although several components differentially expressed in patients with ovarian, endometrial, and cervical cancer of the mTOR were identified, there are only a few investigated downstream actors in gynecological cancer connecting them with YB-1. Our analysis shows that YB-1 is an important player impacting AKT as well as the downstream actors interacting with mTOR such as epidermal growth factor receptor (EGFR), Snail or E-cadherin.

3 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Jure KnezJure Knez
Jure Knez
LMLeyla Al Mahdawi
Leyla Al Mahdawi
Iztok TakačIztok Takač
Iztok Takač
Monika SobocanMonika Sobocan
Monika Sobocan
Endometrial cancer is the most common gynecological cancer in developed countries. The disease is diagnosed with increasing frequency in younger women, commonly also in their reproductive age. The standard treatment of endometrial cancer is surgical in the form of hysterectomy and bilateral salpingo-oophorectomy, and this precludes future fertility in younger women. The current challenge is to identify the group of women with endometrial cancer and low-risk features that would benefit from more conservative treatment options. More focus in management needs to be aimed towards the preservation of quality of life, without jeopardizing oncological outcomes. In this review, we analyze the current approaches to identification of women for conservative management and evaluate the success of different medical options for treatment and surgical techniques that are fertility sparing. We also elaborate on the future perspectives, focusing on the incorporation of molecular characterization of endometrial cancer to fertility preservation algorithms. Future studies should focus specifically on identifying reliable clinical and molecular predictive markers in this group of young women. With improved knowledge and better risk assessment, the precision medicine is the path towards improved understanding of the disease and possibly widening the group of women that could benefit from treatment methods preserving their fertility.